A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes-Reference-Cited by-同舟云学术

A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes

Published:2021-07 Issue:7 Volume:2 Page:851-863.e3
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Schneider Carolin V.,Schneider Kai Markus,Conlon Donna M.,Park Joseph,Vujkovic Marijana,Zandvakili Inuk,Ko Yi-An,Trautwein Christian,Carr Rotonya M.,Strnad Pavel,Thaiss Christoph A.,Rader Daniel J.

Funder

German Research Foundation

NIH

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum;Hardy;Annu. Rev. Pathol.,2016

3. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis;Buch;Nat. Genet.,2015

4. A protein-truncating HSD17B13 variant and protection from chronic liver disease;Abul-Husn;N. Engl. J. Med.,2018

5. A missense variant in mitochondrial amidoxime reducing component 1 gene and protection against liver disease;Emdin;PLoS Genet.,2020

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of an induced pluripotent stem cell (iPSC) line (EXSURGi001-A) from a patient homozygous for the p.Ala165Thr mutation in the MTARC1 gene;Stem Cell Research;2024-10

2. Liver-specific mitochondrial amidoxime–reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse models;Hepatology Communications;2024-05

3. Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis;Nature Genetics;2024-04-17

4. Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches;European Journal of Medical Research;2024-03-20

5. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies;Pharmacological Reviews;2024-01-30